Three Liquid-Liquid Phase Separation-Related Genes Associated with Prognosis in Glioma
DOI: https://doi.org/10.2147/pgpm.s442000
2024-04-23
Pharmacogenomics and Personalized Medicine
Abstract:Ling Lv, 1 Xin Zhang, 1 Yajun Liu, 1 Xutong Zhu, 2 Ruihan Pan, 1 Lifa Huang 1 1 Department of Neurosurgery, the First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine), Hangzhou, Zhejiang, People's Republic of China; 2 The First School of Clinical Medicine, Zhejiang Chinese Medical University, Hangzhou, Zhejiang, People's Republic of China Correspondence: Lifa Huang, Department of Neurosurgery, the First Affiliated Hospital of Zhejiang Chinese Medical University (Zhejiang Provincial Hospital of Chinese Medicine), No. 54 Youdian Road, Hangzhou, 310006, People's Republic of China, Tel/Fax +86-57186620251, Email Purpose: Dysregulated liquid-liquid phase separation (LLPS) instigates tumorigenesis through biomolecular condensate dysfunction. However, the association between LLPS-associated genes and glioma remains underexplored. Patients and Methods: Differentially expressed genes (DEGs) of glioma were obtained from the GSE50161 dataset, including 34 glioma and 13 normal samples. We analyzed differentially expressed LLPS-related genes in glioma from public databases. These genes informed refined molecular subtyping on the TCGA-glioma dataset. CIBERSORT assessed immune cell infiltration across three subclusters. A prognostic model was devised using univariate and lasso Cox regressions on intersecting genes. Prognostic gene expression was validated in glioma cells via RT-qPCR. Results: A total of 673 differentially expressed LLPS-associated genes were identified in glioma. Three distinct molecular subtypes (C1, C2, and C3) of glioma were obtained with a marked variance in the expression of immune checkpoint genes PD1 and PDL1. Differences in immune cell infiltration were observed across subtypes. In addition, a tri-gene prognostic signature ( TAGLN2, NTNG2 , and IGF2BP2 ) was derived with significant survival differences between high and low-risk groups. The prognostic model displayed impressive AUC values for 1, 3, and 5-year survival in both training and validation sets. Further analysis highlighted a notable correlation between the three prognostic genes and immune cells in glioma samples. Furthermore, we found the upregulation of TAGLN2 and IGF2BP2 and the downregulation of NTNG2 in glioma tumors and cells. Conclusion: This study innovatively uncovers the significant role of LLPS-related genes in glioma tumor grading and prognosis. The constructed tri-gene prognostic model holds promise for enhancing personalized prognosis assessments and optimizing immunotherapy strategies for glioma patients. Keywords: liquid-liquid phase separation, glioma, prognostic model, molecular subtype, immune cell infiltration Liquid-liquid phase separation (LLPS) is an intrinsic biophysical process within the cellular environment, leading to the formation of membrane-less compartments characterized by concentrated proteins and RNA molecules. 1 LLPS underlies the genesis of numerous membraneless organelles, including stress granules, processing bodies (P-bodies), and nuclear speckles. By orchestrating specific biological macromolecules into discrete membraneless compartments, cells can adeptly execute vital functions such as chromatin restructuring, and the regulation of gene transcription and translation. 2 LLPS is instrumental for many physiological functions, and its dysregulation can lead to pathological conditions. For example, pharmacological modulation of LLPS within the core regulatory circuitry attenuates metastatic potential and reverses chemoresistance in osteosarcoma. 3 The induction of ILF3 liquid–liquid phase separation promotes esophageal cancer progression. 4 Aberrant phase separation has been implicated in several diseases, including neurodegenerative disorders and cancers. 5–7 Thus, we believe that investigating the role of LLPS in oncology could enhance our comprehension of tumor pathogenesis, improve prognosis prediction, and refine personalized treatment choices. Glioma represents the most prevalent malignant primary brain tumor, constituting over 81% of central nervous system malignancies. 8,9 Originating from glial or precursor cells, it typically evolves into astrocytoma, oligodendroglioma, ependymoma, or oligoastrocytoma. 10 Significant heterogeneities in glioma patient prognosis and therapeutic responses consistently pose major clinical challenges. 11 Considering these challenges, our study sought to pinpoint these heterogeneities by examining the LLPS patterns in glioma patients. The variety of molecular subtypes is often related to the treatment and prognosis of patients. In this study, t -Abstract Truncated-
pharmacology & pharmacy